These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17428708)

  • 21. Triptans for treatment of acute pediatric migraine: a systematic literature review.
    Major PW; Grubisa HS; Thie NM
    Pediatr Neurol; 2003 Nov; 29(5):425-9. PubMed ID: 14684238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden.
    Bigal M; Rapoport A; Aurora S; Sheftell F; Tepper S; Dahlof C
    Headache; 2007 Apr; 47(4):475-9. PubMed ID: 17445096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials.
    Dahlöf CG
    Cephalalgia; 2006 Feb; 26(2):98-106. PubMed ID: 16426262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of clinical safety data for sumatriptan nasal powder administered by a breath powered exhalation delivery system in the acute treatment of migraine.
    Silberstein SD
    Expert Opin Drug Saf; 2018 Jan; 17(1):89-97. PubMed ID: 28994319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal sumatriptan for the acute treatment of migraine in children.
    Ueberall MA; Wenzel D
    Neurology; 1999 Apr; 52(7):1507-10. PubMed ID: 10227648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation and evaluation of nasal mucoadhesive microspheres of sumatriptan succinate.
    Jain SA; Chauk DS; Mahajan HS; Tekade AR; Gattani SG
    J Microencapsul; 2009 Dec; 26(8):711-21. PubMed ID: 19888880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Triptanes in the treatment of migraine. A review based on three Cochrane reviews].
    Tfelt-Hansen P; Iversen HK
    Ugeskr Laeger; 2006 May; 168(19):1850-3. PubMed ID: 16756800
    [No Abstract]   [Full Text] [Related]  

  • 29. Subcutaneous sumatriptan relieved migraine-like headache in two adolescents with aseptic meningitis.
    Prokhorov S; Khanna S; Alapati D; Pallimalli SL
    Headache; 2008 Sep; 48(8):1235-6. PubMed ID: 18547266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A fixed-dose combination of sumatriptan and naproxen for migraine.
    Med Lett Drugs Ther; 2008 Jun; 50(1288):45-6. PubMed ID: 18551089
    [No Abstract]   [Full Text] [Related]  

  • 31. Question 2: Does intranasal sumatriptan use relieve migraine in children and young people?
    Yong JW; Anand G
    Arch Dis Child; 2013 Jan; 98(1):82-4. PubMed ID: 23255042
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical implications for breath-powered powder sumatriptan intranasal treatment.
    Tepper SJ
    Headache; 2013 Sep; 53(8):1341-9. PubMed ID: 23809006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient information regarding subcutaneous self-administration of sumatriptan (imitrex).
    Rothrock JF
    Headache; 2007 Apr; 47(4):639. PubMed ID: 17445120
    [No Abstract]   [Full Text] [Related]  

  • 34. Effectiveness of nasal sumatriptan in 5- to 12-year-old children.
    Hershey AD; Powers SW; LeCates S; Bentti AL
    Headache; 2001; 41(7):693-7. PubMed ID: 11554957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Aspirin, triptan tablet, nasal spray, injection. Even the most severe migraine capitulates].
    Wiedemann B
    MMW Fortschr Med; 2001 Apr; 143(16):6. PubMed ID: 11368000
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of triptans for pediatric migraines.
    Eiland LS; Hunt MO
    Paediatr Drugs; 2010 Dec; 12(6):379-89. PubMed ID: 21028917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the relationship between age and treatment response in migraine.
    Maas HJ; Danhof M; Della Pasqua OE
    Cephalalgia; 2009 Jul; 29(7):772-80. PubMed ID: 19281474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Triptanes are still effective in the middle of a migraine attack. Best effect before reaching high point].
    MMW Fortschr Med; 2002 Mar; 144(13):50. PubMed ID: 12001592
    [No Abstract]   [Full Text] [Related]  

  • 39. Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies.
    Dahlöf C
    Cephalalgia; 1999 Nov; 19(9):769-78. PubMed ID: 10595285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics of intranasal sumatriptan.
    Fuseau E; Petricoul O; Moore KH; Barrow A; Ibbotson T
    Clin Pharmacokinet; 2002; 41(11):801-11. PubMed ID: 12190330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.